EC clears Perrigo's GSK transaction; Australian experts want Hospira's Remicade biosim covered;

@FiercePharma: Beef producers lash out at USDA's choice of Humane Society vet for advisory panel. FierceAnimalHealth article | Follow @FiercePharma

@EricPFierce: Mylan recalls more of the cancer meds made at Indian plants hit with FDA warning letter. More from FiercePharmaManufacturing | Follow @EricPFierce

@CarlyHFierce: Purdue hones abuse-deterrent edge with painkiller safety campaign. FiercePharmaMarketing story | Follow @CarlyHFierce

> The European Commission (EC) has cleared Perrigo's ($PRGO) acquisition of certain products--such as cold and flu drugs and pain treatments--from GlaxoSmithKline ($GSK). Report

> The European Medicines Agency (EMA) has validated Pfizer's ($PFE) application to market breast cancer treatment Ibrance, clearing the final hurdle before an actual review. More

> A committee of experts in Australia has recommended that Hospira's ($HSP) Remicade biosimilar Inflectra be added to the country's pharmaceutical benefits program. Release

> U.K. cancer patients are missing out on targeted oncology therapies because of failings in the NHS' diagnostic services, a new report says. More

> Anti-infectives maker Xellia has moved its North American headquarters to a Raleigh, NC, plant it bought from Fresenius Kabi last summer. Report

Medical Device News

@FierceMedDev: IYCMI yesterday: Startup nabs $5.3M to back 2015 launch for connected fertility thermometer, app. Article | Follow @FierceMedDev

@VarunSaxena2: Cannabics Pharma's extended-release medical marijuana capsules available in Colorado. FierceDrugDelivery story | Follow @VarunSaxena2

@EmilyWFierce: Lilly faces patent-infringement fight over 'Take-n-Slide' drug adherence tool. More from FiercePharma | Follow @EmilyWFierce

> Gauss raises $3.3M for real-time surgical blood loss monitoring system, iPad app. More

> Patient monitoring company expanding in Milwaukee, adding 150 jobs. Article

Biotech News

@FierceBiotech: Baxalta bets on 'external innovation' to meet its $8.5B goal and ward off Shire. Article | Follow @FierceBiotech

@JohnCFierce: In a first for diabetes, Lilly and Boehringer's Jardiance prevents heart attacks, strokes in trial. FiercePharma story | Follow @JohnCFierce

@DamianFierce: Turing has a new Form D reflecting that $90M claim but now including warrants and a loan. SEC form | Follow @DamianFierce

> 23andMe brings on Dean Schorno as CFO, operations head. Chutes and Ladders

> Takeda rolls toward EU approval with its heir to Velcade. Article

> Raptor buys into cystic fibrosis with a $418M deal. Item

And Finally... Jimmy Carter--who is taking Merck's ($MRK) Keytruda to treat melanoma that has metastasized to the brain--may benefit from new advances in immuno-oncology. More

Suggested Articles

Merck’s Keytruda went up against chemo in a head-to-head colorectal cancer battle—and won.

While the FDA gave an emergency green light to chloroquine's use against coronavirus, European regulators are restricting the drug to clinical trials.

Biocon has finally satisfied the FDA that its insulin production plant in Malaysia is ready for prime time.